Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1999 | 3 |
2001 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer.
J Urol. 1999 Jan;161(1):62-5.
J Urol. 1999.
PMID: 10037369
Clinical Trial.
NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.
Zippe C, Pandrangi L, Potts JM, Kursh E, Novick A, Agarwal A.
Zippe C, et al. Among authors: pandrangi l.
Anticancer Res. 1999 Jul-Aug;19(4A):2621-3.
Anticancer Res. 1999.
PMID: 10470205
Item in Clipboard
Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat.
Sharma S, Zippe CD, Pandrangi L, Nelson D, Agarwal A.
Sharma S, et al. Among authors: pandrangi l.
J Urol. 1999 Jul;162(1):53-7. doi: 10.1097/00005392-199907000-00014.
J Urol. 1999.
PMID: 10379739
Item in Clipboard
Screening and monitoring for bladder cancer: refining the use of NMP22.
Ponsky LE, Sharma S, Pandrangi L, Kedia S, Nelson D, Agarwal A, Zippe CD.
Ponsky LE, et al. Among authors: pandrangi l.
J Urol. 2001 Jul;166(1):75-8.
J Urol. 2001.
PMID: 11435827
Clinical Trial.
Item in Clipboard
Cite
Cite